340B Legislation Introduced
On Thursday, December 21st, Rep. Larry Bucshon (R-IN) and Rep. Scott Peters (D-CA) introduced the 340B PAUSE Act, H.R. 4710, in the U.S. House of Representatives. The bill would “amend…
NIH Director Says March-In Rights Cannot Be Used to Lower Drug Prices
National Institutes of Health (NIH) Director Francis Collins stated yesterday that the agency does not have the authority to use its “march-in” rights as a tool to lower drug prices. …
Opioid Epidemic Declared Public Health Emergency – Implications for Ryan White Grantees
Last week, President Trump declared the opioid epidemic a national public health emergency. The declaration allows federal agencies “to use every appropriate emergency authority to fight the opioid crisis.” The…
House E&C Oversight Subcommittee Hearing on 340B
The House Energy & Commerce Subcommittee on Oversight and Investigations held its second hearing on the 340B drug program last Wednesday. Five covered entities – including RWC-340B member AIDS Resource…
Bipartisan Letter from Senators Opposing Part B Cuts
This week, 57 Senators signed a bipartisan letter to CMS urging the agency to reconsider its proposal to reduce Medicare Part B reimbursement for 340B drugs. The proposed rule would…
Upcoming House and Senate Hearings
The House Energy and Commerce (E&C) Committee will hold a hearing focused on the 340B program before the Oversight and Investigations Subcommittee on Wednesday, October 11 at 10 a.m. The hearing…
Mylan to Refund Covered Entities for EpiPen Overcharges
Mylan will refund 340B covered entities a total of $19.3 million for overcharges on the EpiPen as part of its recent settlement agreement with the Department of Justice resolving claims…
Recent GAO Report on 340B Program Oversight
The Government Accountability Office (GAO) submitted a report on 340B program oversight as part of its testimony during the House Energy and Commerce’s Subcommittee on Oversight and Investigations hearing on…
Draft Executive Order on Drug Prices
We received a copy of what we believe to be the Trump Administration’s draft executive order on drug prices that would direct HRSA to scale back the 340B Program. According…
Senate HELP to Hold Hearing on Drug Spending
The Senate Health, Education, Labor and Pensions (HELP) Committee will hold a hearing “in the near future” on drug spending. A bipartisan group of senators who serve on the HELP…